Redmile Group LLC Reduces Position in HCA Healthcare, Inc. (NYSE:HCA)

Redmile Group LLC trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 20.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 52,487 shares of the company’s stock after selling 13,613 shares during the quarter. Redmile Group LLC’s holdings in HCA Healthcare were worth $17,506,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of HCA. Atlantic Edge Private Wealth Management LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $27,000. LifeSteps Financial Inc. purchased a new stake in shares of HCA Healthcare in the first quarter valued at about $33,000. Rise Advisors LLC purchased a new position in HCA Healthcare during the first quarter worth about $36,000. Northwest Investment Counselors LLC purchased a new stake in HCA Healthcare in the 1st quarter valued at approximately $36,000. Finally, Activest Wealth Management acquired a new stake in shares of HCA Healthcare in the 1st quarter valued at approximately $40,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on HCA. Barclays boosted their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Oppenheimer raised their price objective on HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. SVB Leerink upped their target price on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research note on Friday, June 28th. Finally, JPMorgan Chase & Co. upped their price target on shares of HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a report on Thursday, May 30th. Four analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $341.12.

Insider Transactions at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 973 shares of the business’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the sale, the senior vice president now directly owns 22,365 shares in the company, valued at approximately $6,977,880. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Michael S. Cuffe sold 1,600 shares of the business’s stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the transaction, the executive vice president now owns 34,124 shares in the company, valued at approximately $10,544,316. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Kathryn A. Torres sold 973 shares of the firm’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the sale, the senior vice president now owns 22,365 shares in the company, valued at $6,977,880. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 18,254 shares of company stock valued at $6,022,057. Insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Up 1.1 %

NYSE HCA traded up $3.95 during trading hours on Monday, hitting $358.73. The company had a trading volume of 1,195,183 shares, compared to its average volume of 1,160,175. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $361.12. The firm’s 50 day moving average is $330.79 and its 200 day moving average is $323.36. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The company has a market capitalization of $93.95 billion, a price-to-earnings ratio of 17.88, a P/E/G ratio of 1.36 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same period in the previous year, the company posted $4.29 earnings per share. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 22.43 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.74%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s payout ratio is currently 13.16%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.